December 27, 2017 / 7:54 AM / 6 months ago

BRIEF-Lidds With Immune-Stimulating Agent Demonstrates Significant Efficacy

Dec 27 (Reuters) - LIDDS AB:

* REG-LIDDS: NANOZOLID® WITH IMMUNE-STIMULATING AGENT DEMONSTRATES SIGNIFICANT EFFICACY

* ‍COMPLETED FIRST STEPS IN PROJECT ASSESSING FEASIBILITY OF USING NANOZOLID FOR INTRATUMORAL IMMUNOTHERAPY​

* SAYS ‍NANOZOLID TECHNOLOGY CAN BE LEVERAGED TO DEVELOP NOVEL IMMUNOTHERAPIES THAT CAN ACT LOCALLY OR INTRATUMORALLY.​

* ‍SUCCESSFUL COMBINATION TREATMENT COULD INCREASE RESPONSE RATES AND EFFICACY RATES OF CURRENT IMMUNOTHERAPIES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below